Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05389462
Title A Dose-Escalation and Dose-Expansion Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ADC Therapeutics S.A.
Indications

endometrial cancer

Advanced Solid Tumor

pancreatic cancer

peritoneum cancer

ovarian cancer

liposarcoma

osteosarcoma

leiomyosarcoma

urinary bladder cancer

synovial sarcoma

fallopian tube cancer

chondrosarcoma

cervical cancer

Ewing sarcoma

Therapies

ADCT-601 + Gemcitabine

ADCT-601

Age Groups: adult | child | senior
Covered Countries USA

Additional content available in CKB BOOST